Delivery Order SPE2DX22D0049-SPE2D826FA0MA
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $14,745.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,920.32 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,379.98 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order represents a non-competitive award issued under AmerisourceBergen's existing indefinite delivery contract vehicle. The contractor, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $791,968.14 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $91,278.31 firm fixed price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on September 17, 2025, with an ultimate completion date of September 18, 2025. This non-set-aside contract is a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The contract will be performed at the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,314.62 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on July 27, 2025, with an ultimate completion date of July 28, 2025. This firm fixed price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $33,215.58 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 1, 2025, with an ultimate completion date of October 2, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical (designated SPE2DX and running through December...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $28,637.82 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $47,051.52 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's significant indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was competitively procured with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,946.92 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 4, 2025, with an ultimate completion date of October 6, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA0MADelivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,314.62 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on October 13, 2025, with an ultimate completion date of October 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation and is to be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order exemplifies the company's ongoing role as a primary vendor for the Defense Health Agency and broader federal healthcare procurement needs through the DLA Troop Support Medical's Pharmaceutical Prime Vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 10/13/25 |